6523 Stock Overview
Through its subsidiaries, offers medical devices, healthcare IT solutions, and life science products and services primarily in Japan.
Snowflake Score | |
---|---|
Valuation | 5/6 |
Future Growth | 3/6 |
Past Performance | 0/6 |
Financial Health | 4/6 |
Dividends | 3/6 |
PHC Holdings Corporation Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | JP¥1,143.00 |
52 Week High | JP¥1,623.00 |
52 Week Low | JP¥1,056.00 |
Beta | 0.83 |
11 Month Change | 8.24% |
3 Month Change | -12.48% |
1 Year Change | -24.60% |
33 Year Change | n/a |
5 Year Change | n/a |
Change since IPO | -56.88% |
Recent News & Updates
Is PHC Holdings Corporation (TSE:6523) Trading At A 47% Discount?
Jun 08PHC Holdings Corporation's (TSE:6523) Prospects Need A Boost To Lift Shares
Apr 20Shareholder Returns
6523 | JP Medical Equipment | JP Market | |
---|---|---|---|
7D | -2.6% | 1.7% | 1.5% |
1Y | -24.6% | 6.3% | 18.8% |
Return vs Industry: 6523 underperformed the JP Medical Equipment industry which returned 4.5% over the past year.
Return vs Market: 6523 underperformed the JP Market which returned 17.8% over the past year.
Price Volatility
6523 volatility | |
---|---|
6523 Average Weekly Movement | 4.3% |
Medical Equipment Industry Average Movement | 3.7% |
Market Average Movement | 3.9% |
10% most volatile stocks in JP Market | 7.4% |
10% least volatile stocks in JP Market | 2.1% |
Stable Share Price: 6523 has not had significant price volatility in the past 3 months.
Volatility Over Time: 6523's weekly volatility (4%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2013 | 9,403 | Kay Deguchi | phchd.com |
PHC Holdings Corporation, through its subsidiaries, offers medical devices, healthcare IT solutions, and life science products and services primarily in Japan. It operates through Diabetes Management, Healthcare Solutions, and Diagnostic & Life Sciences segments. The company offers blood glucose monitoring systems, continuous glucose monitoring systems, and diabetes application; patient and record billing software, including electronic medical record system, electronic medication history system, and healthcare note service; and diagnostic testing products, which include clinical testing, diagnostic reagents and instruments, and drug development support products.
PHC Holdings Corporation Fundamentals Summary
6523 fundamental statistics | |
---|---|
Market cap | JP¥144.10b |
Earnings (TTM) | -JP¥12.89b |
Revenue (TTM) | JP¥353.90b |
0.4x
P/S Ratio-11.2x
P/E RatioIs 6523 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
6523 income statement (TTM) | |
---|---|
Revenue | JP¥353.90b |
Cost of Revenue | JP¥195.93b |
Gross Profit | JP¥157.98b |
Other Expenses | JP¥170.87b |
Earnings | -JP¥12.89b |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | -102.27 |
Gross Margin | 44.64% |
Net Profit Margin | -3.64% |
Debt/Equity Ratio | 205.4% |
How did 6523 perform over the long term?
See historical performance and comparison